XOVL (XOVL)

XOVL (XOVL) is a company listed on the BATS.

As of Oct 23, 2026: returns 1 week -1.7%.

XOVL (formerly known as Bioventus Inc.) is a medical technology company specializing in the development and commercialization of minimally invasive surgical solutions and orthobiologics. As of May 2026, the company generates revenue through three primary segments: Pain Management (approx. 45%), consisting of joint injection therapies like Durolane and Gelsyn; Surgical Solutions (approx.

XOVL financial model: income statement, cash flow and balance sheet